FDA Approves a Groundbreaking New Treatment for IgA Kidney Disease

If you or someone you love has been diagnosed with IgA nephropathy (IgAN), there is encouraging news. The U.S. Food and Drug Administration (FDA) has approved a new treatment called TRUTAKNA (Atacicept-vymj) for adults with primary IgA nephropathy who are at risk of worsening kidney disease. This marks

• Published date: 30-07-2026 12:55 PM